(VIANEWS) – Peabody Energy Corporation (BTU), Cathay General Bancorp (CATY), Thermo Fisher Scientific (TMO) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Peabody Energy Corporation (BTU)

58.8% sales growth and 21.9% return on equity

Peabody Energy Corporation is involved in coal mining in the United States of America, Japan, Taiwan and Australia as well as in China, India. Vietnam, South Korea, South Korea and Australia.

Peabody Energy Corporation’s sales growth this year is anticipated to be 43.2% and a negative 10.6% for next year.

Year-on-year quarterly revenue growth grew by 6.2%, now sitting on 3.36B for the twelve trailing months.

Volume

Today’s last reported volume for Peabody Energy Corporation is 5055310 which is 25.08% below its average volume of 6748430.

Peabody Energy Corporation’s sales growth is a negative 0% for the current quarter and 58.8% for the next. The company’s growth estimates for the current quarter and the next is 1328.6% and 939.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.9%.

Volatility

Peabody Energy Corporation’s last day, last week, and last month’s current intraday variation average was 5.02%, 2.02%, and 3.94%, respectively.

Peabody Energy Corporation’s highest amplitude of average volatility was 7.41% (day), 6.10% (last week), and 7.66% (last month), respectively.

Peabody Energy Corporation’s Stock Yearly Top and Bottom Value

Peabody Energy Corporation’s stock is valued at $20.73 at 20:22 EST, way below its 52-week high of $33.29 and way above its 52-week low of $8.58.

Peabody Energy Corporation’s Moving Average

Peabody Energy Corporation’s value is below its 50-day moving average of $22.74 and way above its 200-day moving average of $18.03.

2. Cathay General Bancorp (CATY)

19.6% sales growth and 12.28% return on equity

Cathay General Bancorp is the holding company of Cathay Bank. It offers a variety of commercial banking products to professionals and individuals as well as small- to medium-sized business owners in the United States.

Cathay General Bancorp’s sales growth this year is expected to be 19.2% and 9.5% for next year.

Year-on-year quarterly revenue growth grew by 3.3%, now sitting on 673.77M for the twelve trailing months.

Volume

Today’s last reported volume for Cathay General Bancorp is 301905 which is 0.67% above its average volume of 299883.

Cathay General Bancorp’s sales growth is a negative 0% for the ongoing quarter and 19.6% for the next. The company’s growth estimates for the ongoing quarter and the next is 35.5% and 26.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.28%.

Volatility

Cathay General Bancorp’s last day, last week, and last month’s current intraday variation average was 1.83%, 1.38%, and 1.19%, respectively.

Cathay General Bancorp’s highest amplitude of average volatility was 2.61% (day), 2.40% (last week), and 2.40% (last month), respectively.

Cathay General Bancorp’s Stock Yearly Top and Bottom Value

Cathay General Bancorp’s stock is valued at $41.17 at 20:22 EST, way under its 52-week high of $48.88 and way higher than its 52-week low of $37.08.

Cathay General Bancorp’s Moving Average

Cathay General Bancorp’s value is higher than its 50-day moving average of $39.89 and under its 200-day moving average of $43.04.

3. Thermo Fisher Scientific (TMO)

19.4% sales growth and 19.98% return on equity

Thermo Fisher Scientific Inc. offers analytical and other tools, lab equipment, software and consumables worldwide.

Thermo Fisher Scientific’s sales growth this year is expected to be 8.7% and 4.7% for next year.

Year-on-year quarterly revenue growth grew by 19.3%, now sitting on 41.12B for the twelve trailing months.

Volume

Today’s last reported volume for Thermo Fisher Scientific is 1223640 which is 10.62% below its average volume of 1369150.

Thermo Fisher Scientific’s sales growth for the next quarter is 19.4%. The company’s growth estimates for the present quarter and the next is a negative 10.7% and negative -12.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.98%.

Volatility

Thermo Fisher Scientific’s last day, last week, and last month’s current intraday variation average was 0.13%, 1.43%, and 2.26%, respectively.

Thermo Fisher Scientific’s highest amplitude of average volatility was 2.17% (day), 3.59% (last week), and 2.99% (last month), respectively.

Thermo Fisher Scientific’s Stock Yearly Top and Bottom Value

Thermo Fisher Scientific’s stock is valued at $589.90 at 20:22 EST, way under its 52-week high of $672.34 and way above its 52-week low of $497.83.

Thermo Fisher Scientific’s Moving Average

Thermo Fisher Scientific’s value is above its 50-day moving average of $541.19 and higher than its 200-day moving average of $583.70.

4. Hexcel Corporation (HXL)

15.6% sales growth and 3.22% return on equity

Hexcel Corporation and its subsidiaries develop, manufacture, and market structural materials to be used in aerospace, defense and industrial markets.

Hexcel Corporation’s sales growth this year is anticipated to be 20% and 14.6% for next year.

Year-on-year quarterly revenue growth grew by 25.9%, now sitting on 1.4B for the twelve trailing months.

Volume

Today’s last reported volume for Hexcel Corporation is 506437 which is 23.41% below its average volume of 661301.

Hexcel Corporation’s sales growth for the next quarter is 15.6%. The company’s growth estimates for the ongoing quarter and the next is 275% and 153.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.22%.

Volatility

Hexcel Corporation’s last day, last week, and last month’s current intraday variation average was 2.45%, 2.17%, and 1.46%, respectively.

Hexcel Corporation’s highest amplitude of average volatility was 3.57% (day), 3.92% (last week), and 3.39% (last month), respectively.

Hexcel Corporation’s Stock Yearly Top and Bottom Value

Hexcel Corporation’s stock is valued at $57.11 at 20:22 EST, way below its 52-week high of $64.16 and way above its 52-week low of $46.77.

Hexcel Corporation’s Moving Average

Hexcel Corporation’s worth is above its 50-day moving average of $54.02 and above its 200-day moving average of $55.36.

5. Pfizer (PFE)

8.9% sales growth and 31.87% return on equity

Pfizer Inc. designs, manufactures and markets healthcare products around the world.

Pfizer’s sales growth this year is anticipated to be 28.8% and a negative 25.2% for next year.

Year-on-year quarterly revenue growth grew by 106.8%, now sitting on 81.29B for the twelve trailing months.

Volume

Today’s last reported volume for Pfizer is 12330100 which is 44.3% below its average volume of 22139000.

Pfizer’s sales growth for the next quarter is 8.9%. The company’s growth estimates for the current quarter and the next is 89.7% and 41%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.87%.

Volatility

Pfizer’s last day, last week, and last month’s current intraday variation average was 0.42%, 1.27%, and 1.05%, respectively.

Pfizer’s highest amplitude of average volatility was 2.90% (day), 4.21% (last week), and 2.50% (last month), respectively.

Pfizer’s Stock Yearly Top and Bottom Value

Pfizer’s stock is valued at $50.71 at 20:22 EST, way under its 52-week high of $61.71 and way above its 52-week low of $38.82.

Pfizer’s Moving Average

Pfizer’s value is higher than its 50-day moving average of $50.59 and above its 200-day moving average of $50.24.

Previous days news about Pfizer(PFE)

  • Pfizer reports big profit and revenue beats, as covid drug sales increase by nearly $9 billion. According to MarketWatch on Thursday, 28 July, "Shares of Pfizer Inc. gained 0.3% in premarket trading Thursday, after the pharmaceutical giant reported big second-quarter profit and revenue beats, driven primarily by "strong contributions" from its COVID drugs Comirnaty and Paxlovid. ", "For 2022, Pfizer nudged up its guidance for adjusted EPS to $6.30 to $6.45 from $6.25 to $6.45 and affirmed its revenue outlook of $98.0 billion to $102 billion, which includes expected Comirnaty revenue of about $32 billion and Paxlovid revenue of about $22 billion. "
  • According to FXStreet on Thursday, 28 July, "Other earnings due Wednesday include Apple, Amazon, Mastercard, Pfizer and Merck."
  • According to MarketWatch on Friday, 29 July, "Both Moderna and Pfizer are developing bivalent boosters that equally target the original strain of the virus and the BA.4 and BA.5 variants. "
  • According to MarketWatch on Friday, 29 July, "The Biden administration has decided against offering COVID boosters to people under 50 for now, preferring to wait until retooled Pfizer and Moderna shots become available in September that could perform better against the omicron BA.5 subvariant, the New York Times reported Thursday. "

6. Union Pacific Corporation (UNP)

8.9% sales growth and 38.25% return on equity

Union Pacific Corporation engages in railroading in the United States through Union Pacific Railroad Company as its subsidiary.

Union Pacific Corporation’s sales growth this year is anticipated to be 10.9% and 6% for next year.

Year-on-year quarterly revenue growth grew by 29.7%, now sitting on 20.57B for the twelve trailing months.

Volume

Today’s last reported volume for Union Pacific Corporation is 1886010 which is 31.73% below its average volume of 2762620.

Union Pacific Corporation’s sales growth is a negative 0% for the present quarter and 8.9% for the next. The company’s growth estimates for the ongoing quarter and the next is 30.8% and 14.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 38.25%.

Volatility

Union Pacific Corporation’s last day, last week, and last month’s current intraday variation average was 1.59%, 1.69%, and 1.51%, respectively.

Union Pacific Corporation’s highest amplitude of average volatility was 2.15% (day), 2.23% (last week), and 2.10% (last month), respectively.

Union Pacific Corporation’s Stock Yearly Top and Bottom Value

Union Pacific Corporation’s stock is valued at $227.10 at 20:22 EST, under its 52-week high of $249.94 and way higher than its 52-week low of $193.14.

Union Pacific Corporation’s Moving Average

Union Pacific Corporation’s value is under its 50-day moving average of $235.08 and above its 200-day moving average of $222.74.

7. Restaurant Brands International (QSR)

8.3% sales growth and 28.17% return on equity

Restaurant Brands International Inc. operates and owns fast-food restaurants that are franchised under the brands of Popeyes (PLK), Burger King(BK) and Tim Hortons (TH).

Restaurant Brands International’s sales growth this year is anticipated to be 9.6% and 5% for next year.

Year-on-year quarterly revenue growth grew by 11.8%, now sitting on 5.55B for the twelve trailing months.

Volume

Today’s last reported volume for Restaurant Brands International is 1344210 which is 11.79% below its average volume of 1523900.

Restaurant Brands International’s sales growth for the next quarter is 8.3%. The company’s growth estimates for the current quarter and the next is 55.6% and 29.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.17%.

Volatility

Restaurant Brands International’s last day, last week, and last month’s current intraday variation average was 0.92%, 1.60%, and 1.55%, respectively.

Restaurant Brands International’s highest amplitude of average volatility was 1.45% (day), 2.08% (last week), and 2.02% (last month), respectively.

Restaurant Brands International’s Stock Yearly Top and Bottom Value

Restaurant Brands International’s stock is valued at $54.43 at 20:22 EST, way below its 52-week high of $71.12 and higher than its 52-week low of $54.18.

Restaurant Brands International’s Moving Average

Restaurant Brands International’s worth is under its 50-day moving average of $58.95 and way under its 200-day moving average of $63.86.

8. IDEXX Laboratories (IDXX)

7.5% sales growth and 112.62% return on equity

IDEXX Laboratories, Inc., along with its subsidiaries, creates, manufactures, distributes, products and services primarily to the companion animal veterinary, poultry, milk, and water testing markets around the world.

IDEXX Laboratories’s sales growth this year is anticipated to be 7% and 11.5% for next year.

Year-on-year quarterly revenue growth grew by 11.1%, now sitting on 3.22B for the twelve trailing months.

Volume

Today’s last reported volume for IDEXX Laboratories is 553367 which is 22.23% below its average volume of 711619.

IDEXX Laboratories’s sales growth for the next quarter is 7.5%. The company’s growth estimates for the current quarter and the next is a negative 32.9% and 11.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 112.62%.

Volatility

IDEXX Laboratories’s last day, last week, and last month’s current intraday variation average was 0.26%, 1.29%, and 1.98%, respectively.

IDEXX Laboratories’s highest amplitude of average volatility was 2.27% (day), 2.86% (last week), and 3.33% (last month), respectively.

IDEXX Laboratories’s Stock Yearly Top and Bottom Value

IDEXX Laboratories’s stock is valued at $398.23 at 20:22 EST, way under its 52-week high of $706.51 and way above its 52-week low of $318.50.

IDEXX Laboratories’s Moving Average

IDEXX Laboratories’s value is above its 50-day moving average of $366.40 and way below its 200-day moving average of $503.38.

LEAVE A REPLY

Please enter your comment!
Please enter your name here